Insulet Corp (PODD)

$140.53 -0.07 (-0.05%)
Market Cap 9.75B
Revenue (ttm) 2.71B
Net Income (ttm) 247.10M
EPS (ttm) N/A
PE Ratio 23.95
Forward PE 21.59
Profit Margin 9.12%
Debt to Equity Ratio 0.67
Volume 1,334,461
Avg Vol 1,700,910
Day's Range N/A - N/A
Shares Out 69.35M
Stochastic %K 58%
Beta 1.08
Analysts Sell
Price Target $171.58

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that...

Industry: Medical Devices
Sector: Healthcare
Phone: 978 600 7000
Address:
100 Nagog Park, Acton, United States
Butters33
Butters33 Sep. 21 at 2:28 PM
$PODD - PODD dominates the type 1 diabetes market. I do not believe type 2 diabetics will ever wear insulin pumps. I am bullish long term but worry about the short term.
1 · Reply
deepthinker
deepthinker Sep. 18 at 1:44 PM
$BBNX This company is going to crush hapless $TNDM, and start taking patch pump market share from $PODD in 2027.
0 · Reply
bulltrades1234
bulltrades1234 Sep. 18 at 1:40 PM
$PODD depressed stock
0 · Reply
razor4
razor4 Sep. 17 at 9:05 PM
$PODD Lets go to 160 levels
1 · Reply
BriOnH
BriOnH Sep. 16 at 4:47 PM
$SANA $ELDN $DXCM $PODD $TNDM "Australia-based Endo Axiom Pty Ltd has dosed its first human participants with an oral nanoparticle-encapsulated insulin formulation, marking the company's transition to clinical stage after extensive preclinical development. " https://www.chemdiv.com/company/media/pharma-news/2026/endo-axiom-takes-oral-nanoparticle-insulin-into-first-in-human-trial-run/
1 · Reply
deepthinker
deepthinker Sep. 16 at 2:42 PM
$MODD Beta is raising $150 million. That’s really smart. With their patch pump coming, they can really stick the knife in $TNDM, which has only a fake patch pump coming, and begin to chip away at $PODD. These guys do everything right.
0 · Reply
razor4
razor4 Sep. 15 at 9:20 PM
$PODD
1 · Reply
PattyPooner
PattyPooner Sep. 15 at 11:56 AM
$SENS I’d like to see another partnership announced with $MODD, bring in the little guys to grab big boys attention like $PODD, twist and beta are a decent start but would definitely like to see more progress
0 · Reply
bulltrades1234
bulltrades1234 Sep. 14 at 8:30 PM
$PODD nice move a long way to go
0 · Reply
LinzonTard
LinzonTard Sep. 14 at 4:10 PM
$BBNX Big news for BBNX. The FDA approved the tubeless Mint pump and the company is ramping up for commercial deliveries. Also, there was news about their software and an update. The AI software is good, and now is getting better. BBNX is positioning itself to be the market leader in insulin pumps. $PODD market share will be impacted in my opinion - it will take a year or so...
0 · Reply
Latest News on PODD
Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum

Sep 18, 2026, 7:00 AM EDT - 3 days ago

Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum

Insulet Transcript: Wells Fargo 21st Annual Healthcare Conference

Sep 9, 2026, 2:15 PM EDT - 12 days ago

Insulet Transcript: Wells Fargo 21st Annual Healthcare Conference

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD

Aug 27, 2026, 10:07 AM EDT - 25 days ago

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD

Insulet to Participate in Wells Fargo 21st Annual Healthcare Conference

Aug 26, 2026, 7:00 AM EDT - 26 days ago

Insulet to Participate in Wells Fargo 21st Annual Healthcare Conference

Contact Robbins LLP for Information About Leading the Lawsuit That Alleges Insulet Corporation Misled Investors Regarding the Safety and Reliability of its Insulin Delivery Products

Aug 13, 2026, 2:40 PM EDT - 5 weeks ago

Contact Robbins LLP for Information About Leading the Lawsuit That Alleges Insulet Corporation Misled Investors Regarding the Safety and Reliability of its Insulin Delivery Products

Insulet Corporation Investors With Significant Losses Must Act By August 31, 2026

Aug 12, 2026, 8:00 PM EDT - 5 weeks ago

Insulet Corporation Investors With Significant Losses Must Act By August 31, 2026

This Medtech Beat Earnings Estimates. It's the Worst S&P 500 Stock Today.

Aug 5, 2026, 12:17 PM EDT - 6 weeks ago

This Medtech Beat Earnings Estimates. It's the Worst S&P 500 Stock Today.

Insulet Slides: Investor presentation

Aug 5, 2026, 9:00 AM EDT - 6 weeks ago

Insulet Slides: Investor presentation

Insulet cuts sales growth forecast on slower US insulin-pump sales; shares fall

Aug 5, 2026, 8:11 AM EDT - 6 weeks ago

Insulet cuts sales growth forecast on slower US insulin-pump sales; shares fall

Insulet Earnings Call Transcript: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 6 weeks ago

Insulet Earnings Call Transcript: Q2 2026

Insulet Earnings release: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 6 weeks ago

Insulet Earnings release: Q2 2026

Insulet Slides: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 6 weeks ago

Insulet Slides: Q2 2026

Insulet Quarterly report: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 6 weeks ago

Insulet Quarterly report: Q2 2026

Insulet Reports Second Quarter 2026 Results

Aug 5, 2026, 7:00 AM EDT - 6 weeks ago

Insulet Reports Second Quarter 2026 Results

PODD INVESTOR REMINDER: Insulet Corporation Investors Have Until August 31, 2026 To Seek Lead Plaintiff Role

Aug 4, 2026, 7:00 PM EDT - 6 weeks ago

PODD INVESTOR REMINDER: Insulet Corporation Investors Have Until August 31, 2026 To Seek Lead Plaintiff Role

$PODD Fraud Notification: Insulet Sued for Fraud Over Misrepresentations about its Safety Issues – Investors Notified to Contact BFA Law

Jul 24, 2026, 6:36 AM EDT - 1 month ago

$PODD Fraud Notification: Insulet Sued for Fraud Over Misrepresentations about its Safety Issues – Investors Notified to Contact BFA Law

Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss

Jul 14, 2026, 3:00 AM EDT - 2 months ago

Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss

PODD Investors Have Rights - If You Lost Money Investing in Insulet Corporation Contact Robbins LLP for Information About Recovering Your Losses

Jul 13, 2026, 5:14 PM EDT - 2 months ago

PODD Investors Have Rights - If You Lost Money Investing in Insulet Corporation Contact Robbins LLP for Information About Recovering Your Losses

INSULET CORPORATION (PODD) INVESTOR ALERT Investors With Large Losses in Insulet Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Jul 6, 2026, 12:04 PM EDT - 2 months ago

INSULET CORPORATION (PODD) INVESTOR ALERT Investors With Large Losses in Insulet Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Insulet Slides: Investor presentation

Jul 6, 2026, 7:00 AM EDT - 2 months ago

Insulet Slides: Investor presentation

Grabar Law Office Investigates Claims on Behalf of Shareholders of Insulet Corporation (PODD)

Jul 3, 2026, 1:31 PM EDT - 2 months ago

Grabar Law Office Investigates Claims on Behalf of Shareholders of Insulet Corporation (PODD)

Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026

Jul 1, 2026, 7:00 AM EDT - 2 months ago

Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026

20 stocks in the S&P 500 that plunged the most in 2026's first half

Jun 30, 2026, 7:55 AM EDT - 2 months ago

20 stocks in the S&P 500 that plunged the most in 2026's first half

ACN ADBE BR BSX CRM CSGP CTSH

Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors

Jun 25, 2026, 7:00 AM EDT - 2 months ago

Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

Jun 4, 2026, 7:00 AM EDT - 3 months ago

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

Insulet Transcript: 46th Annual William Blair Growth Stock Conference

Jun 3, 2026, 3:00 PM EDT - 3 months ago

Insulet Transcript: 46th Annual William Blair Growth Stock Conference

Insulet Slides: 46th Annual William Blair Growth Stock Conference

Jun 3, 2026, 3:00 PM EDT - 3 months ago

Insulet Slides: 46th Annual William Blair Growth Stock Conference

Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor

Jun 3, 2026, 7:00 AM EDT - 3 months ago

Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor

US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow

May 28, 2026, 10:34 AM EDT - 3 months ago

US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow

Insulet to Participate in William Blair 46th Annual Growth Stock Conference

May 27, 2026, 4:05 PM EDT - 3 months ago

Insulet to Participate in William Blair 46th Annual Growth Stock Conference

Insulet flags dosing defect in some Omnipod devices, sees up to $50 million cost

May 26, 2026, 4:50 PM EDT - 3 months ago

Insulet flags dosing defect in some Omnipod devices, sees up to $50 million cost

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets

May 26, 2026, 4:05 PM EDT - 3 months ago

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets

These 15 S&P 500 stocks could be contrarian ways to play the market's uneven rally

May 20, 2026, 10:05 AM EDT - 4 months ago

These 15 S&P 500 stocks could be contrarian ways to play the market's uneven rally

APH APP AXON CSGP CVNA EL FICO

Insulet Transcript: AGM 2026

May 20, 2026, 8:00 AM EDT - 4 months ago

Insulet Transcript: AGM 2026

Insulet Transcript: Bank of America Global Healthcare Conference 2026

May 13, 2026, 12:20 PM EDT - 4 months ago

Insulet Transcript: Bank of America Global Healthcare Conference 2026

Insulet Slides: FY 2026

May 13, 2026, 12:20 PM EDT - 4 months ago

Insulet Slides: FY 2026

Insulet Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 months ago

Insulet Earnings Call Transcript: Q1 2026

Insulet Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 months ago

Insulet Earnings release: Q1 2026

Insulet Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 months ago

Insulet Slides: Q1 2026

Insulet Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 months ago

Insulet Quarterly report: Q1 2026

Insulet lifts annual revenue forecast after quarterly beat on strong insulin pump demand

May 6, 2026, 7:46 AM EDT - 4 months ago

Insulet lifts annual revenue forecast after quarterly beat on strong insulin pump demand

Insulet Reports First Quarter 2026 Results

May 6, 2026, 7:00 AM EDT - 4 months ago

Insulet Reports First Quarter 2026 Results

Insulet Slides: Investor presentation

May 6, 2026, 7:00 AM EDT - 4 months ago

Insulet Slides: Investor presentation

Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities

May 5, 2026, 7:00 AM EDT - 4 months ago

Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities

Insulet Slides: Omnipod® 5 competitive clinical performance presentation

May 5, 2026, 7:00 AM EDT - 4 months ago

Insulet Slides: Omnipod® 5 competitive clinical performance presentation

Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes

May 4, 2026, 7:00 AM EDT - 4 months ago

Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes

Insulet to Participate in BofA Securities 2026 Health Care Conference

Apr 28, 2026, 7:00 AM EDT - 4 months ago

Insulet to Participate in BofA Securities 2026 Health Care Conference

Insulet Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 5 months ago

Insulet Proxy statement: Proxy filing

Insulet Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 5 months ago

Insulet Proxy statement: Proxy filing

Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

Apr 1, 2026, 7:00 AM EDT - 5 months ago

Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

Insulet Appoints Mike Panos as Chief Commercial Officer

Mar 30, 2026, 8:30 AM EDT - 5 months ago

Insulet Appoints Mike Panos as Chief Commercial Officer

Insulet recalls some insulin devices in US over leakage risk

Mar 12, 2026, 5:22 PM EDT - 6 months ago

Insulet recalls some insulin devices in US over leakage risk

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.

Mar 12, 2026, 4:05 PM EDT - 6 months ago

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

Mar 11, 2026, 4:01 PM EDT - 6 months ago

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Mar 10, 2026, 7:00 AM EDT - 6 months ago

Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Insulet Earnings Call Transcript: Q4 2025

Feb 18, 2026, 8:00 AM EST - 7 months ago

Insulet Earnings Call Transcript: Q4 2025

Insulet Annual report: Q4 2025

Feb 18, 2026, 8:00 AM EST - 7 months ago

Insulet Annual report: Q4 2025

Insulet Earnings release: Q4 2025

Feb 18, 2026, 8:00 AM EST - 7 months ago

Insulet Earnings release: Q4 2025

Insulet Slides: Q4 2025

Feb 18, 2026, 8:00 AM EST - 7 months ago

Insulet Slides: Q4 2025

Insulet beats quarterly estimates on strong demand for wearable insulin pumps

Feb 18, 2026, 7:55 AM EST - 7 months ago

Insulet beats quarterly estimates on strong demand for wearable insulin pumps

Insulet Reports Fourth Quarter and Full Year 2025 Results

Feb 18, 2026, 7:00 AM EST - 7 months ago

Insulet Reports Fourth Quarter and Full Year 2025 Results

Insulet Slides: Investor presentation

Feb 18, 2026, 7:00 AM EST - 7 months ago

Insulet Slides: Investor presentation

Butters33
Butters33 Sep. 21 at 2:28 PM
$PODD - PODD dominates the type 1 diabetes market. I do not believe type 2 diabetics will ever wear insulin pumps. I am bullish long term but worry about the short term.
1 · Reply
deepthinker
deepthinker Sep. 18 at 1:44 PM
$BBNX This company is going to crush hapless $TNDM, and start taking patch pump market share from $PODD in 2027.
0 · Reply
bulltrades1234
bulltrades1234 Sep. 18 at 1:40 PM
$PODD depressed stock
0 · Reply
razor4
razor4 Sep. 17 at 9:05 PM
$PODD Lets go to 160 levels
1 · Reply
BriOnH
BriOnH Sep. 16 at 4:47 PM
$SANA $ELDN $DXCM $PODD $TNDM "Australia-based Endo Axiom Pty Ltd has dosed its first human participants with an oral nanoparticle-encapsulated insulin formulation, marking the company's transition to clinical stage after extensive preclinical development. " https://www.chemdiv.com/company/media/pharma-news/2026/endo-axiom-takes-oral-nanoparticle-insulin-into-first-in-human-trial-run/
1 · Reply
deepthinker
deepthinker Sep. 16 at 2:42 PM
$MODD Beta is raising $150 million. That’s really smart. With their patch pump coming, they can really stick the knife in $TNDM, which has only a fake patch pump coming, and begin to chip away at $PODD. These guys do everything right.
0 · Reply
razor4
razor4 Sep. 15 at 9:20 PM
$PODD
1 · Reply
PattyPooner
PattyPooner Sep. 15 at 11:56 AM
$SENS I’d like to see another partnership announced with $MODD, bring in the little guys to grab big boys attention like $PODD, twist and beta are a decent start but would definitely like to see more progress
0 · Reply
bulltrades1234
bulltrades1234 Sep. 14 at 8:30 PM
$PODD nice move a long way to go
0 · Reply
LinzonTard
LinzonTard Sep. 14 at 4:10 PM
$BBNX Big news for BBNX. The FDA approved the tubeless Mint pump and the company is ramping up for commercial deliveries. Also, there was news about their software and an update. The AI software is good, and now is getting better. BBNX is positioning itself to be the market leader in insulin pumps. $PODD market share will be impacted in my opinion - it will take a year or so...
0 · Reply
Tickrtrends
Tickrtrends Sep. 11 at 11:59 PM
$PODD PODD fair value on TickrTrends https://stocks.tickrtrends.com/podd
0 · Reply
anvesti
anvesti Sep. 11 at 7:33 PM
Anvesti closed a long position $PODD 🔴 -6.99% $142.38 → $132.43 Model: ml_model_v3 · Score: 82.0 Reason: Stop Loss · 3 days
0 · Reply
BriOnH
BriOnH Sep. 11 at 6:32 PM
$SANA $ELDN $DXCM $PODD $TNDM It appears it is safe to assume Endo Axiom's Smart Oral insulin is now in human(s). Please Jesus let this work. This will ineffably transform the lives for us T1D's. Sana with sc451 is still on the horizon with Ph 1/2 to begin this year, IMHO the best potential option. Tego + Cadaveric islets is here RIGHT NOW with 12 out of 12 people (functionally) cured. T1D your days are numbered bitch. https://www.sydney.edu.au/news-opinion/news/2026/09/10/oral-insulin-drug-achieves-a-critical-milestone--.html
1 · Reply
bulltrades1234
bulltrades1234 Sep. 11 at 3:25 PM
$PODD at this point we see $125 I feel
0 · Reply
UrbanKoala
UrbanKoala Sep. 10 at 7:05 PM
$PODD Well… apparently the market heard “open a position” and said “here’s a better entry.” Down ~4% since my starter, but my thesis hasn’t changed. This was never about calling the exact bottom — I wanted to start building while the stock was being ignored rather than chase it after momentum returns. Watching closely here. If the fundamentals remain intact, continued weakness may turn this into an add opportunity rather than a reason to panic.
2 · Reply
bulltrades1234
bulltrades1234 Sep. 10 at 5:51 PM
$PODD going to hit $125 I feel
0 · Reply
MODDBlueInMyBlood
MODDBlueInMyBlood Sep. 10 at 5:04 PM
$MODD $MODD $TNDM $PODD $MDT @Stef_Gee Lets debate MODD stock LETS TALK ANALYTICS LETS SETTLE THIS
1 · Reply
MODDBlueInMyBlood
MODDBlueInMyBlood Sep. 10 at 4:45 PM
$MODD my days on this app may be numbered. My recent post about @Stef_Gee was taken down I AM HERE FOR REAL STOCK ANALYSIS. But most people are too afraid to face the truth. Ready to debate $MODD with anyone $TNDM $PODD $MDT If anyone doubts modd is the next big thing i am ready to defend it. Respond.
1 · Reply
deepthinker
deepthinker Sep. 10 at 3:53 PM
$PODD They’ve lost $15.6 billion of market cap from the 52-week high.
1 · Reply
JInvestTrade
JInvestTrade Sep. 10 at 11:46 AM
$SENS $DXCM $TNDM $PODD $ABT https://lnkd.in/p/eTiFrp-W
0 · Reply
NorthstarT1D
NorthstarT1D Sep. 9 at 6:58 PM
$PODD pretty sure they said 30%+ earnings growth for this year. That means this growth stock will move into deep value territory if the price doesn't move up.
2 · Reply
bulltrades1234
bulltrades1234 Sep. 9 at 6:58 PM
$PODD at this point we can just hope for a good ER for a couple of quarters to get back in the 200’s range
0 · Reply